Invasive techniques to access subcutaneous adipose tissue for glucose monitoring are successfully applied in type1 diabetic and critically ill patients. During critical illness, the addition of a lactate sensor might enhance prognosis and early intervention.
Our objective was to evaluate SAT as a site for lactate measurement in critically ill patients.